In this section you can read all the latest news about counterfeit and substandard medicines from around Europe and the world.
EVENT: Innovation in nanomedicines: enhancing patient safety through regulatory clarity – 30 November 2020 – 11:00 CET
On behalf of the European Alliance for Access to Safe Medicines, you are kindly invited to join the upcoming virtual roundtable event on “Innovation in
FMD event summary – 30 September 2020
Event summary of “Patient safety and the implementation of the Falsified Medicines Directive (FMD) in the hospital environment” held as a live webinar on 30th
EVENT: Patient safety and the implementation of the Falsified Medicines Directive in the hospital environment – 30 September
Led by MEP Manuel Pizarro (S&D) this live webinar will be especially useful for hospital pharmacists and their teams across the EU. Following the entry
Article in the highly subscribed EurActiv journal
Commission urged to consider common regulatory framework for nanomedicines” supports the EAASM goals for nanomedicines and nanosimilars for regulatory clarity The lack of a fit-for-purpose